NASDAQ
CDMOP

Avid Bioservices, Inc

Prices are adjusted according to historical splits.

Avid Bioservices, Inc Stock Price

Vitals

Today's Low:
$25.0602
Today's High:
$25.0602
Open Price:
$25.0602
52W Low:
$17.51
52W High:
$27.7499
Prev. Close:
$25.0602
Volume:
400

Company Statistics

Market Cap.:
$0.221 billion
Book Value:
0.822
Revenue TTM:
$0.070 billion
Operating Margin TTM:
-3.57%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
-3.68%
Return on Assets TTM:
-1.5%
Return on Equity TTM:
-5.35%

Company Profile

Avid Bioservices, Inc had its IPO on 2018-01-08 under the ticker symbol CDMOP.

The company operates in the sector and industry. Avid Bioservices, Inc has a staff strength of 222 employees.

Stock update

Shares of Avid Bioservices, Inc opened at $25.06 at the start of the last trading session i.e. 2021-04-13.

The stocks traded within a range of $25.06 - $25.06, and closed at $25.06.

This is a 0% increase from the previous day's closing price.

A total volume of 400 shares were traded at the close of the day’s session.

In the last one week, shares of Avid Bioservices, Inc have increased by +0.24%.

Avid Bioservices, Inc's Key Ratios

Avid Bioservices, Inc has a market cap of $0.221 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Avid Bioservices, Inc’s revenue was $0.070 billion with a gross profit of $0.000 billion and an EBITDA of $0.001 billion. The EBITDA ratio measures Avid Bioservices, Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Avid Bioservices, Inc’s operating margin was -3.57% while its return on assets stood at -1.5% with a return of equity of -5.35%.

In Q2.3333333333333, Avid Bioservices, Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 66.5%.

Avid Bioservices, Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
None

Its diluted EPS in the last 12-months stands at $-0.129 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Avid Bioservices, Inc’s profitability.

Avid Bioservices, Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Avid Bioservices, Inc stock pays annual dividends of $2.62 per share, indicating a yield of 9.7% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Avid Bioservices, Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Avid Bioservices, Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Avid Bioservices, Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Avid Bioservices, Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Avid Bioservices, Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$25.06
52-Week High
$27.7499
52-Week Low
$17.51
Analyst Target Price
$None

Avid Bioservices, Inc stock is currently trading at $25.06 per share. It touched a 52-week high of $27.7499 and a 52-week low of $27.7499. Analysts tracking the stock have a 12-month average target price of $None.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 482.7% of the company’s stock are held by insiders while 0.5% are held by institutions.

Frequently Asked Questions About Avid Bioservices, Inc

The stock symbol (also called stock or share ticker) of Avid Bioservices, Inc is CDMOP

The IPO of Avid Bioservices, Inc took place on 2018-01-08

Similar Industry Stocks ()

Last Price
Chg
Chg%
$3.02
-0.33
-9.85%
CLPS Inc (CLPS)
$1.22
0
0%
$111.89
-3.51
-3.04%
$31.01
-1.89
-5.74%
$29.22
-0.38
-1.28%
$0.24
-0.01
-5.03%
$21.7
-0.2
-0.91%
$108.61
0
0%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

Address

2642 Michelle Drive, Tustin, CA, United States, 92780